Actinogen Medical Limited (ACW.AX)
AUD 0.03
(3.85%)
AUD 0.03
(3.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -12.83 Million AUD | 19.11% |
| 2023 | -15.87 Million AUD | -20.49% |
| 2022 | -13.17 Million AUD | -123.13% |
| 2021 | -5.9 Million AUD | 33.75% |
| 2020 | -8.91 Million AUD | 7.24% |
| 2019 | -9.6 Million AUD | -0.47% |
| 2018 | -9.56 Million AUD | -108.0% |
| 2017 | -4.59 Million AUD | 39.35% |
| 2016 | -7.58 Million AUD | -39.74% |
| 2015 | -5.42 Million AUD | -1200.92% |
| 2014 | -416.97 Thousand AUD | 8.84% |
| 2013 | -457.39 Thousand AUD | 58.79% |
| 2012 | -1.1 Million AUD | -5.59% |
| 2011 | -1.05 Million AUD | -4.56% |
| 2010 | -1 Million AUD | -13.69% |
| 2009 | -884.17 Thousand AUD | -53.12% |
| 2008 | -577.44 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -23.18 Million AUD | -46.08% |
| 2024 Q2 | -12.56 Million AUD | 0.0% |
| 2024 Q4 | -1.39 Million AUD | 0.0% |
| 2023 Q2 | -8.48 Million AUD | 0.0% |
| 2023 FY | -15.87 Million AUD | -20.49% |
| 2023 Q4 | -7.38 Million AUD | 0.0% |
| 2022 Q2 | -5.8 Million AUD | 0.0% |
| 2022 FY | -13.17 Million AUD | -123.13% |
| 2022 Q4 | -7.37 Million AUD | 0.0% |
| 2021 Q4 | -3.49 Million AUD | 0.0% |
| 2021 Q2 | -2.41 Million AUD | 0.0% |
| 2021 FY | -5.9 Million AUD | 33.75% |
| 2020 Q4 | -4.14 Million AUD | 0.0% |
| 2020 FY | -8.91 Million AUD | 7.24% |
| 2020 Q2 | -4.76 Million AUD | 0.0% |
| 2019 Q4 | -7.26 Million AUD | 0.0% |
| 2019 FY | -9.6 Million AUD | -0.47% |
| 2019 Q2 | -7.12 Million AUD | 0.0% |
| 2018 Q2 | -3.61 Million AUD | 0.0% |
| 2018 FY | -9.56 Million AUD | -108.0% |
| 2018 Q4 | -2.64 Million AUD | 0.0% |
| 2017 Q2 | -1.84 Million AUD | 0.0% |
| 2017 FY | -4.59 Million AUD | 39.35% |
| 2017 Q4 | -1.33 Million AUD | 0.0% |
| 2016 Q2 | -1.16 Million AUD | 0.0% |
| 2016 Q4 | -2.46 Million AUD | 0.0% |
| 2016 FY | -7.58 Million AUD | -39.74% |
| 2015 Q4 | -4.2 Million AUD | 0.0% |
| 2015 FY | -5.42 Million AUD | -1200.92% |
| 2015 Q2 | -1.22 Million AUD | 0.0% |
| 2014 FY | -416.97 Thousand AUD | 8.84% |
| 2014 Q4 | -279.76 Thousand AUD | 0.0% |
| 2014 Q2 | -137.21 Thousand AUD | 0.0% |
| 2013 FY | -457.39 Thousand AUD | 58.79% |
| 2013 Q4 | -138.86 Thousand AUD | -21.44% |
| 2013 Q3 | -114.34 Thousand AUD | -407.81% |
| 2013 Q2 | -22.51 Thousand AUD | 91.88% |
| 2013 Q1 | -277.46 Thousand AUD | 0.0% |
| 2012 Q4 | -277.46 Thousand AUD | 0.0% |
| 2012 Q1 | -262.76 Thousand AUD | 0.0% |
| 2012 Q2 | -277.46 Thousand AUD | -5.59% |
| 2012 FY | -1.1 Million AUD | -5.59% |
| 2012 Q3 | -277.46 Thousand AUD | 0.0% |
| 2011 Q3 | -262.76 Thousand AUD | 0.0% |
| 2011 FY | -1.05 Million AUD | -4.56% |
| 2011 Q4 | -262.76 Thousand AUD | 0.0% |
| 2011 Q2 | -262.76 Thousand AUD | -4.56% |
| 2011 Q1 | -251.3 Thousand AUD | 0.0% |
| 2010 Q1 | -221.04 Thousand AUD | 0.0% |
| 2010 FY | -1 Million AUD | -13.69% |
| 2010 Q4 | -251.3 Thousand AUD | 0.0% |
| 2010 Q3 | -251.3 Thousand AUD | 0.0% |
| 2010 Q2 | -251.3 Thousand AUD | -13.69% |
| 2009 FY | -884.17 Thousand AUD | -53.12% |
| 2009 Q1 | -144.36 Thousand AUD | 0.0% |
| 2009 Q2 | -221.04 Thousand AUD | -53.12% |
| 2009 Q3 | -221.04 Thousand AUD | 0.0% |
| 2009 Q4 | -221.04 Thousand AUD | 0.0% |
| 2008 FY | -577.44 Thousand AUD | 0.0% |
| 2008 Q4 | -144.36 Thousand AUD | 0.0% |
| 2008 Q3 | -144.36 Thousand AUD | 0.0% |
| 2008 Q2 | -144.36 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | -144.013% |
| Acrux Limited | -9.83 Million AUD | -30.557% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -190.149% |
| Biome Australia Limited | -1.91 Million AUD | -571.06% |
| BTC Health Limited | 1.05 Million AUD | 1316.635% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -4.3% |
| CSL Limited | 5.64 Billion AUD | 100.227% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 71.342% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 126.123% |
| Noxopharm Limited | -7.53 Million AUD | -70.391% |
| PharmAust Limited | -6.65 Million AUD | -92.817% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -77.541% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -78.656% |
| PYC Therapeutics Limited | -38.85 Million AUD | 66.959% |
| Race Oncology Limited | -13.38 Million AUD | 4.047% |
| Starpharma Holdings Limited | -15.15 Million AUD | 15.304% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 232.135% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 12.659% |
| Memphasys Limited | -2.7 Million AUD | -374.815% |
| Nyrada Inc. | -4.56 Million AUD | -181.536% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -779.909% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -319.237% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -116.209% |
| Patrys Limited | -3.53 Million AUD | -262.77% |
| Dimerix Limited | -25.05 Million AUD | 48.767% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 105.682% |
| Orthocell Limited | -11.68 Million AUD | -9.912% |
| Imugene Limited | -140.93 Million AUD | 90.89% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -45.766% |
| Immutep Limited | -44.93 Million AUD | 71.429% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -78.492% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 34.501% |
| Nanollose Limited | -1.24 Million AUD | -927.263% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -501.745% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -524.295% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -346.763% |
| Biotron Limited | -5.15 Million AUD | -149.244% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 72.804% |
| Tissue Repair Ltd | -4.87 Million AUD | -163.313% |
| AnteoTech Limited | -11.72 Million AUD | -9.486% |
| Hexima Limited | -1 Million AUD | -1172.762% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 80.282% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 41.777% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -179.766% |
| Immuron Limited | -5.8 Million AUD | -121.319% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -126.389% |